Osteoarthritis, KneeVIKEPNCT04618016
Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
An observational study of Osteoarthritis, Knee and Arthritis, Rheumatoid, run by Aesculap AG at 8 sites in 2 countries.
Trial summary
Prospective, randomized, single-blind, multinational, long-term study for the evaluation of the clinical outcome, oxidation profile and wear analysis of medium cross-linked Polyethylene with and without Vitamin E for total knee arthroplasty Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Osteoarthritis, Knee, Arthritis, Rheumatoid, Intra-Articular Fractures
- What is being tested?
- UHMWPE with Vitamin E and UHMWPE without Vitamin E
- Type of treatment
- Medical device
- How many people
- 605 participants
- Where
- 8 sitesin 2 countries
- Study dates
- 8 Mar 2021to Oct 2034
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: multicentric
Who may be able to join
- Indication for a total knee replacement with a mobile-bearing UC or PS inlay
- Written informed consent for participating at the clinical study
- Willingness and mental ability to participate at the long-term follow-up examinations
Who cannot join
- Patient age < 18 and > 80 years
- Pregnancy
- High risk patients (ASA class >3)
Trial locations and contacts
8 sites in 2 countries.
8 sites in 2 countries
Germany6 sites
Park-Klinik Weißensee
Berlin, 13086
Lukas Krankenhaus
Bünde, North Rhine-Westphalia, 32257
Waldkliniken Eisenberg
Eisenberg, 07607
Brüderhaus Koblenz
Koblenz, Rhineland-Palatinate, 56073
Krankenhaus Reinbek, St. Adolf Stift
Reinbek, 21465
Universitätsklinikum Rostock, Klinik für Orthopädie
Rostock, 18057
France2 sites
CHU Amiens-Picardie
Amiens, 80054
Hôpital Sud - CHU de Grenoble
Échirolles, Isere, 38130
About this study
Official title: Prospective, Randomized, Single-blind, Multinational, Long-term Study for the Evaluation of the Clinical Outcome, Oxidation Profile and Wear Analysis of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
Prospective, randomized, single-blind, multinational, long-term study for the evaluation of the clinical outcome, oxidation profile and wear analysis of medium cross-linked Polyethylene with and without Vitamin E for total knee arthroplasty
- Conditions
- Osteoarthritis, Knee, Arthritis, Rheumatoid, Intra-Articular Fractures, Joint Instability, Genu Valgum or Varum
- Being tested
- UHMWPE with Vitamin E, UHMWPE without Vitamin E
- Keywords
- Total Knee Arthroplasty, Range of motion, Treatment outcome, Ultrahighmolecular Weight Polyethylene with Vitamin E
- Medical subject headings
- Osteoarthritis, Knee, Arthritis, Rheumatoid, Intra-Articular Fractures, Joint Instability, Genu Valgum
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
UHMWPE with Vitamin EDevice
e.motion Pro (PS and UC) with MXE gliding surface
UHMWPE without Vitamin EDevice
e.motion Pro (PS and UC) with β-PE gliding surface
| Study group | Role | What they receive |
|---|---|---|
| With Vitamin E | Not described Receives: Device: UHMWPE with Vitamin E | |
| Without Vitamin E | Not described Receives: Device: UHMWPE without Vitamin E |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical Outcome measured with the KSS [performance]
The KSS is an examiner-administrated standard clinical evaluation tool reporting results for patients undergoing TKA. It separates findings in the operated knee (kKSS) score from findings related to the patient's function (fKSS), which might be affected by co-morbidities. The two sub-scores are reported separately ranging from 0 points (worst result) to 100 points (best results), as well as summarized score, total KSS. Final grading of total KSS results Scores of 160 to 200 will be rated as excellent, 140 to 159 as good, 120 to 139 as fair, and less than 120 as poor.
Measured: 10 years postoperatively
Secondary outcomes (8)
Survival rate
Kaplan-Meier Analysis is a standard statistical method to describe the survival of human subjects or medical products over a defined time period. The revision-free survival rate is the performance indicator of the product under investigation and confirms the clinical outcome of the knee prosthesis. Information on survival of the implant will be collected until the last follow-up of the study patients took place.
Measured: until the last follow-up at 10 years postoperatively
Progress of Clinical Outcome [Oxford Knee Score] compared to baseline
The Oxford Knee Score is a reliable 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing total knee replacement. It is short, reproducible, valid and sensitive to clinically important changes over time. Each of the 12 questions on the OKS is scored in the same way with the score decreasing as the reported symptoms increase (i.e. become worse). All questions are laid out with response categories denoting least (or no) symptoms to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0), as detailed for question 1 below. This method, when summed, produces overall scores running from 0 to 48 with 48 being the best outcome, (to convert from the 60-12 system to the 0-48 system and vice versa subtract the score from 60).
Measured: Preoperatively, 3 months, 12 months, 3 years, 5 years, 7 years, 10 years
Quality of Life [EQ-5D-5L]
EQ-5D is a standardized 5-dimension 5-level measure of the health status and is developed by the EuroQol Group in order to have a simple and generic measure for clinical and economic assessment. Instructions for the user are directly included into the questionnaire and it consists of two pages. One cover five different dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression) and the other one the EQ visual Analogue Scale (EQ-VAS). The VAS scale records the self rated health status of the patient from the level "the worst health you can imagine" to "the best health you can imagine".
Measured: Preoperatively, 3 months, 12 months, 5 years, 10 years
Comparison of Radiographic evaluation over time
Imaging will be used to evaluate the implant status as well as device condition and potential presence of device-related Adverse Events including fracture, wear, loosening or radiolucencies.
Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Comparison of Radiographic alignment over time
Alignment (femoral-knee baseline angle, tibial-knee baseline angle, femoral-tibial angle (mechanical))
Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Oxidation profile and wear analysis of available retrievals
Available retrievals of explanted investigational products will be analysed by the biomechanical laboratory of the sponsor. Therefore any retrieval has to be returned to the Sponsor's facility after its revision in order to perform these analyses. Special focus of theses analyses are the oxidation profile, the wear behaviour, the mechanics and the cumulative linear abrasion of these retrievals. These measurements can further analyse the in-vivo performance of the device of the reference and investigational product
Measured: During the course of the study up to 10 years postoperatively
Further analysis of patients having a revision of the primary implant
In case a patient requires the revision of the primary implanted knee prosthesis, additional information on the revision surgery shall be collected. The reason for revision together with the clinical symptoms shall be documented. Further examinations (e.g. arthroscopy) prior to the revision and the date of revision surgery is to be documented. If pre revision radiographs are taken as part of the clinical routine, the results of the radiographic analysis shall be documented in the respective CRF.
Measured: During the course of the study up to 10 years postoperatively
(Serious) Adverse Events
During the course of the study, any upcoming intra- or postoperative (serious) adverse device events or effects related or not related to the product under investigation, will be documented. The total number of AEs will be summarized and further evaluated by the sponsor and reported according to local legislation and necessity. Recorded complications will be categorized and analyzed in order to assess the safety of the investigational product.
Measured: During the course of the study up to 10 years postoperatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Nov 2020
- Study start8 Mar 2021
- Primary completion31 Dec 2024
- Study completionOct 2034 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Osteoarthritis, KneeStudies of the same condition, open and under way.
- More trials run by Aesculap AGThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 605 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aesculap AG
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Raylytic GmbH, B. Braun Medical France
- Responsible party
- Sponsor
- Investigators
- Wolfram Mittelmeier, Prof. Dr., Principal investigator, Orthopädische Uniklinik Rostock, Direktor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04618016
- Sponsor's protocol ID
- AAG-O-H-1906
- Acronym
- VIKEP
- Status last verified
- Oct 2026
- First submitted
- 27 Oct 2020
- Last updated
- 20 Oct 2026
- Results posted
- No
Publications
Maier K, Selig M, Haddouche A, Haunschild M, Hauschild O, Khalili I, Kirschberg J, Lutter C, Menges M, Mertl P, Niemeier A, Rubens-Duval B, Mittelmeier W. Vitamin E-enriched medium cross-linked polyethylene in total knee arthroplasty (VIKEP): clinical outcome, oxidation profile, and wear analysis in comparison to standard polyethylene-study protocol for a randomized controlled trial. Trials. 2024 Jan 5;25(1):27. doi: 10.1186/s13063-023-07811-1.
PubMed 38183062
Study at a glance
From the registry record, last updated by the sponsor on 20 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective, Randomized, Single-blind, Multinational, Long-term Study for the Evaluation of the Clinical Outcome, Oxidation Profile and Wear Analysis of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
- ClinicalTrials.gov ID
- NCT04618016
- Acronym / sponsor ID
- VIKEP / AAG-O-H-1906
- Conditions
- Osteoarthritis, Knee, Arthritis, Rheumatoid, Intra-Articular Fractures, Joint Instability, Genu Valgum or Varum
- Keywords
- Total Knee Arthroplasty, Range of motion, Treatment outcome, Ultrahighmolecular Weight Polyethylene with Vitamin E
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 605 participants (actual)
- Lead sponsor
- Aesculap AGIndustry (pharma, biotech, devices)
- Collaborators
- Raylytic GmbH, B. Braun Medical France
- Study start
- 8 Mar 2021 (actual)
- Primary completion
- 31 Dec 2024 (actual)
- Study completion
- Oct 2034 (estimated)
- First posted
- 5 Nov 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prospective, randomized, single-blind, multinational, long-term study for the evaluation of the clinical outcome, oxidation profile and wear analysis of medium cross-linked Polyethylene with and without Vitamin E for total knee arthroplasty
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| With Vitamin E | – | Device: UHMWPE with Vitamin E |
| Without Vitamin E | – | Device: UHMWPE without Vitamin E |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- multicentric
Key inclusion criteria (3 listed)
- Indication for a total knee replacement with a mobile-bearing UC or PS inlay
- Written informed consent for participating at the clinical study
- Willingness and mental ability to participate at the long-term follow-up examinations
Key exclusion criteria (3 listed)
- Patient age < 18 and > 80 years
- Pregnancy
- High risk patients (ASA class >3)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| UHMWPE with Vitamin Ee.motion Pro (PS and UC) with MXE gliding surface | Device | With Vitamin E |
| UHMWPE without Vitamin Ee.motion Pro (PS and UC) with β-PE gliding surface | Device | Without Vitamin E |
Primary outcome
Clinical Outcome measured with the KSS [performance]
Time frame: 10 years postoperatively
The KSS is an examiner-administrated standard clinical evaluation tool reporting results for patients undergoing TKA. It separates findings in the operated knee (kKSS) score from findings related to the patient's function (fKSS), which might be affected by co-morbidities. The two sub-scores are reported separately ranging from 0 points (worst result) to 100 points (best results), as well as summarized score, total KSS. Final grading of total KSS results Scores of 160 to 200 will be rated as excellent, 140 to 159 as good, 120 to 139 as fair, and less than 120 as poor.
8 secondary outcomes
Survival rate
Time frame: until the last follow-up at 10 years postoperatively
Progress of Clinical Outcome [Oxford Knee Score] compared to baseline
Time frame: Preoperatively, 3 months, 12 months, 3 years, 5 years, 7 years, 10 years
Quality of Life [EQ-5D-5L]
Time frame: Preoperatively, 3 months, 12 months, 5 years, 10 years
Comparison of Radiographic evaluation over time
Time frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Comparison of Radiographic alignment over time
Time frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Oxidation profile and wear analysis of available retrievals
Time frame: During the course of the study up to 10 years postoperatively
Further analysis of patients having a revision of the primary implant
Time frame: During the course of the study up to 10 years postoperatively
(Serious) Adverse Events
Time frame: During the course of the study up to 10 years postoperatively
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Oct 2026.
- Derived from this study: PubMed 38183062Maier K, Selig M, Haddouche A, Haunschild M, Hauschild O, Khalili I, Kirschberg J, Lutter C, Menges M, Mertl P, Niemeier A, Rubens-Duval B, Mittelmeier W. Vitamin E-enriched medium cross-linked polyethylene in total knee arthroplasty (VIKEP): clinical outcome, oxidation profile, and wear analysis in comparison to standard polyethylene-study protocol for a randomized controlled trial. Trials. 2024 Jan 5;25(1):27. doi: 10.1186/s13063-023-07811-1.
Related trials for Osteoarthritis, Knee
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Wolfram Mittelmeier, Prof. Dr. principal investigator
Orthopädische Uniklinik Rostock, Direktor
8 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarthritis, Knee and Arthritis, Rheumatoid, run by Aesculap AG at 8 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in Germany, France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical Outcome measured with the KSS [performance] (time frame: 10 years postoperatively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04618016, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.